Long-term efficacy and safety of raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase III trials

Subjects

Subjects :

Raltegravir -- Dosage and administration
Raltegravir -- Research
HIV infection -- Drug therapy
HIV infection -- Research
Drug resistance -- Research
Clinical trials -- Research
Creatine kinase -- Physiological aspects
Creatine kinase -- Research
Health
Health care industry

Details

Language :

English

ISSN :

10584838

Volume :

50

Issue :

4

Database :

Gale General OneFile

Journal :

Clinical Infectious Diseases

Publication Type :

Academic Journal

Accession number :

edsgcl.219696031